Skip to content

Evaluation of the effect of magnesium sulfate in renal colic patients

Evaluation of the effect of magnesium sulfate on the intensity and duration of pain in renal colic patients by a double-blind clinical trial in the case and control groups

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230726058930N2
Enrollment
160
Registered
2023-11-18
Start date
2023-11-11
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group: A dose of 30 mg of Ketorolac from Abidi Company plus 15 mg/kg of 50% magnesium sulfate from Shahid Ghazi Pharmaceuticals Company in 500 ml of normal saline is injec

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Clinical diagnosis of renal colic Age between 18 and 55 years Having a pain intensity > 5 based on the analog vision scale (VAS)

Exclusion criteria

Exclusion criteria: History of seizures Any heart, liver, kidney or metabolic disease Fever (oral temperature > 38 degrees Celsius) Systolic blood pressure less than 90 mm Hg pregnancy acute abdomen Taking pargoric medicine 3 hours before going to the emergency room History of drug addiction or allergy Taking calcium channel blockers Recent gastrointestinal bleeding, active peptic ulcer or recent perforation

Design outcomes

Primary

MeasureTime frame
Intensity of pain. Timepoint: 0, 30 and 60 minutes after starting the drug. Method of measurement: Visual Analogue Scale.;Systolic blood pressure. Timepoint: 0, 30 and 60 minutes after starting the drug. Method of measurement: Electronic sphygmomanometer.;Diastolic blood pressure. Timepoint: 0, 30 and 60 minutes after starting the drug. Method of measurement: Electronic sphygmomanometer.;Age. Timepoint: upon arrival. Method of measurement: Based on the patient's date of birth.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Vefagh Nematollahi

Ahvaz University of Medical Sciences

vefagh.a@ajums.ac.ir+98 61 3367 5436

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026